Anticancer vaccines.
With the tools of molecular biology and a greater understanding of mechanisms to harness the immune system, effective tumor immunotherapy is becoming a reality. This new class of therapeutics offers a more targeted, and therefore precise, approach to the treatment of cancer. The recent conditional licensure of a xenogeneic DNA vaccine for advanced canine malignant melanoma strongly suggests that immunotherapy can play an extremely important role alongside the classic cancer treatment triad components of surgery, radiation therapy, and chemotherapy.
Bergman
Philip J
PJ
Brightheart Veterinary Centers, 80 Business Park Drive, Suite 110, Armonk, NY 10504, USA. pbergman@brightheartvet.com
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D009369:Neoplasms / Q000517:prevention & control / Q000662:veterinary*
D019496:Cancer Vaccines